• Topics

  • COVID-19 and the liver
  • Public Health and Advocacy

Displaying results 37 - 47 of 47

Display:

12 24 48

Public Health and Advocacy

EASL Policy Statement on Hepatitis C Elimination - RU

PDF

View

Public Health and Advocacy

EASL Policy Statement: risk-based surveillance for hepatocellular carcinoma among patients with cirrhosis

PDF

View

Public Health and Advocacy

EASL Policy Statement: Reducing alcohol harms

PDF

View

Public Health and Advocacy

EASL Policy Dialogues S2 E2: World Liver Day

EASL Policy Dialogues

View

Public Health and Advocacy

EASL Policy Dialogues Episode 1: Drug use, viral hepatitis, and Europe

EASL Policy Dialogues

View

Public Health and Advocacy

EASL Policy Dialogues Episode 3: Liver cancer: The risk of ignorance

EASL Policy Dialogues

View

COVID-19 and the liver

Patient Association COVID-19 Toolkit final

PDF

View

COVID-19 and the liver

Care of Patients with Liver Diseases during the COVID-19 Pandemic

Slide Decks

View

COVID-19 and the liver

Ask EASL: Patient oriented webcast on COVID-19 and the liver

Webcasts

View

COVID-19 and the liver

Ask EASL: podcast on COVID-19 vaccination in patients with liver disease

Podcasts

View

COVID-19 and the liver

Care of Patients with Liver Disease during the COVID-19 Pandemic

PDF

View

Displaying results 37 - 47 of 47

Display:

12 24 48